Newscast – Page 172 – media

“Body-on-a-chip” device screens human heart cells for drug toxicity

A "body-on-a-chip" device that can evaluate the side-effects of drugs on human cells has been developed by researchers at Kyoto University's Institute for Integrated Cell-Material Sciences, according to a study published today in the Royal Society of Chemistry Advances.
- Source: drugdeliverybusiness
- 589
- August 29, 2017
doxorubicin Researches side-effect toxicity
US OKs first drug for dyskinaesia in Parkinson’s patients

US regulators have approved the first and only treatment option to treat dyskinaesia in patients with Parkinson's disease.
- Source: pharmatimes
- 700
- August 28, 2017
dyskinaesia New Approvals Parkinson
US researchers develop anastomosis tool using medical magnets

A new anastomosis tool using a pair of medical magnets has been developed by researchers at the University of California, San Francisco, US.
- Source: medicaldevice-network
- 553
- August 28, 2017
anastomosis Clinical Trials surgical
Takeda partners to develop novel oncology therapies

Collaboration on an oncology drug discovery program was inked between Takeda Pharmaceutical, through its subsidiary Millennium Pharmaceuticals, and Molecular Templates.
- Source: drugdeliverybusiness
- 844
- August 28, 2017
Company Insight Market Views oncology therapy
Merck sees promise in Macrophage Pharma

Merck Ventures has become the latest group to invest in Macrophage Pharma and take a position on the UK biotech’s board of directors.
- Source: pharmatimes
- 633
- August 25, 2017
Clinical Market Views Merck
Patterson Dental, Align Technology sign distribution deal for intraoral scanning system

A distribution agreement for Align’s iTero Element intraoral scanning system has been signed between Patterson Dental, a business unit of Patterson Companies, and Align Technology.
- Source: medicaldevices-business-review
- 510
- August 25, 2017
Company Insight digital Market Views scanning
Titan wins FDA nod to study Parkinson’s implant

Titan Pharmaceuticals’ stated today that their ropinirole implant, designed to treat the symptoms of Parkinson’s disease, was cleared by the FDA today as a new drug application.
- Source: drugdeliverybusiness
- 655
- August 25, 2017
Clinical Trials formulation implant New Approvals Parkinson
GlaxoSmithKline taking heat in its U.K. home turf over shortages of hepatitis B vaccine

GlaxoSmithKline is taking some heat at home over questions about global shortages of its and Merck’s hepatitis B vaccine that triggered rationing in the U.K., although GSK’s supplies to the much larger U.S. market seem to be unaffected.
- Source: fiercepharma
- 586
- August 24, 2017
hepatitis Market Views vaccine
Siemens gets CE-Mark for MR scanner Magnetom Terra

Siemens Healthineers has received CE-Mark for its ultra-high-field 7T magnetic resonance (MR) scanner Magnetom Terra, making it available for neurological and musculoskeletal clinical examinations in Europe.
- Source: medicaldevice
- 539
- August 24, 2017
Clinical MR musculoskeletal neurological
Cel-Sci raises $3.5m for head and neck cancer immunotherapy

Cel-Sci said today that for a Phase III trial of its investigational immunotherapy, it inked an agreement with institutional investors for a $3.5 million registered direct offering.
- Source: drugdeliverybusiness
- 527
- August 24, 2017
Clinical Trials Company Insight immunotherapy

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.